Stoltz J F, Chevraud C, Voisin P, Burdin D, Streiff F, Laxenaire M C
J Mal Vasc. 1986;11(4):344-50.
16 arteritic patients at stages II, III or IV according to Fontaine's ranking system were treated by normovolemic hemodilution (HDN). The procedure consisted of the daily withdrawal of 500 ml of blood, which was replaced by 250 ml of a 4% solution of human albumin and 250 ml of Dextran 40. The procedure was applied, on average, for three days in succession until the patient's hematocrit reached 0.30. The therapy was carried out over a total of 8 weeks in order to maintain hematocrit levels at between 0.30 and 0.35. Improvement was observed in clinical factors: a 100% increase in walking perimeter in stage II patients, disappearance of decubitus pain in stage III patients, wound healings in stage IV patients. The following rheological and platelet parameters were studied: plasma and blood viscosity with hematocrit level 0.40 and for seven speed of scissoring, red blood cell aggregation index, platelet aggregation, MDA platelet levels, plasma BTG. Clinical results revealed that by the 56th day of treatment, 8 patients had improved and 8 remained stationary (the condition of 3 of the "stationary" patients in fact worsened having evolved according to the normal development of arteritic disease). The improvements observed persist several months after normovolemic hemodilution has been discontinued, with the results for the longest studied patient going back as far as 15 months. With regard to the hemorheological parameters (which, on Day 0, are always disturbed), they tend to improve during the hospitalization period and stabilize at levels lying between the values measured on Day 0 and normal values.(ABSTRACT TRUNCATED AT 250 WORDS)
根据Fontaine分级系统处于II、III或IV期的16例动脉炎患者接受了等容血液稀释(HDN)治疗。该操作包括每天抽取500毫升血液,并用250毫升4%的人白蛋白溶液和250毫升右旋糖酐40进行替代。该操作平均连续进行三天,直到患者的血细胞比容达到0.30。治疗总共进行8周,以将血细胞比容水平维持在0.30至0.35之间。观察到临床因素有所改善:II期患者行走周长增加100%,III期患者褥疮疼痛消失,IV期患者伤口愈合。研究了以下流变学和血小板参数:血细胞比容水平为0.40时的血浆和血液粘度以及七种剪切速度下的粘度、红细胞聚集指数、血小板聚集、丙二醛血小板水平、血浆β-血小板球蛋白。临床结果显示,到治疗第56天,8例患者病情改善,8例患者病情稳定(实际上,3例“病情稳定”患者的病情根据动脉炎疾病的正常发展而恶化)。等容血液稀释停止后,观察到的改善持续了几个月,研究时间最长的患者的结果可追溯到15个月。关于血液流变学参数(在第0天总是紊乱),它们在住院期间趋于改善,并稳定在第0天测量值和正常值之间的水平。(摘要截断于250字)